Navigation Links
TB Alliance Names Elana Robertson Senior Vice President, Market Access
Date:7/31/2014

NEW YORK, July 31, 2014 /PRNewswire-USNewswire/ -- TB Alliance, a not-for-profit organization with the mission of developing better, faster and affordable treatments for tuberculosis (TB), announced the appointment of Elana Robertson to Senior Vice President, Market Access. Ms. Robertson joins the organization from Novartis Vaccines, where she was responsible for the company's business in Sub-Saharan Africa and Eastern Europe. In her new role, she will oversee the TB Alliance's efforts to ensure beneficial new TB treatments are available and adopted around the globe, particularly in countries with the highest rates of the disease.

"We are on the cusp of realizing improved treatments to fight tuberculosis—but we can't achieve our mission until those treatments reach people in need," said Mel Spigelman, MD, President and CEO of the TB Alliance. "With her experience heading market expansion efforts in nations with high rates of TB infection, Elana Robertson is the right person to guide that effort."

Ms. Robertson has more than 20 years of experience in the pharmaceutical industry, where she has been responsible for the marketing and commercialization of vaccines and drugs on a global, regional and country level. For the past six years, she served as Head of Sub-Saharan Africa and Other Eastern Europe for Novartis Vaccines, where she was responsible for expanding the company's business in those regions. Prior to joining Novartis, Ms. Robertson held business development, marketing, sales and product management positions at several other pharmaceutical companies, including Roche, Sanofi Pasteur, Schering Plough, Upjohn and Intramed. A native of South Africa, she holds undergraduate and graduate degrees from Stellenbosch University, a marketing diploma from Damelin College, and is pursuing a master's degree in public health from the University of Liverpool in England.

"I've seen the devastation caused by tuberculosis first hand in my home country of South Africa and the burden the current treatments cause on the healthcare system and on patients," said Elana Roberston. "I am excited to join the global fight against this deadly disease by ensuring new drugs, which hold the potential to improve the lives of millions, are available to those in need."

Before joining the pharmaceutical industry, Ms. Robertson was a Lecturer in Physiology at the University of Witwatersrand and a researcher at the University of Stellenbosch.

Every year, 1.3 million people worldwide die from TB. It is estimated that the bacteria that causes TB infects one-third of the world's population. The current treatment is inadequate, and resistance to today's drugs is growing. New, faster-acting, simpler drug regimens are critical to defeating TB.

About the TB Alliance

The Global Alliance for TB Drug Development (TB Alliance) is a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight tuberculosis. Through innovative science and with partners around the globe, we aim to ensure equitable access to faster, better TB cures that will advance global health and prosperity. The TB Alliance operates with funding from Australia Department of Foreign Affairs and Trade, Bill & Melinda Gates Foundation, European Commission, Global Health Innovative Technology Fund, Irish Aid, National Institute of Allergy and Infectious Disease, UNITAID, United Kingdom Department for International Development, United States Agency for International Development, and the United States Food and Drug Administration. For more information, please visit tballiance.org.

Contact:
Joanna Breitstein, +1 646-616-8613 or joanna.breitstein@tballiance.org

Photo - http://photos.prnewswire.com/prnh/20140730/131788


'/>"/>
SOURCE TB Alliance
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
2. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
3. PDR and the iHealth Alliance Announce New Drug Safety Certification for EHRs
4. Physician-Patient Alliance for Health & Safety: Monitoring Technology for PCA Pumps Can Prevent Adverse Events: So Why Are Hospitals Not Using It?
5. Amendia, Inc. and Medline Industries, Inc. Announce Investment and Strategic Business Alliance
6. UBM Canon, the Global MedTech Authority, Announces Strategic Alliance with ITG Market Research, a Preeminent Industry Research Organization
7. Rittal Corp. Joins the HP ProActive Insight Architecture Alliance
8. Elekta and The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Sign Strategic Alliance to Further Cancer Research
9. Premier healthcare alliance honors Atrium Medical Corporation for operational excellence
10. Nonin Medicals Tissue Oximetry System Recognized at Premier Healthcare Alliance Innovation Celebration
11. The UCB-Harvard Research Alliance Expands and Moves Forward
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
(Date:6/23/2016)... , June 23, 2016 ... Oticon , industry leaders in advanced ... launch of Oticon Opn ™, the world,s first ... of possibilities for IoT devices.      (Photo: ... Oticon introduces a number of ,world firsts,: ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
Breaking Medicine News(10 mins):